CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Dutasteride

Last Updated: August 24, 2004
Result type: Reports
Project Number: S0019
Product Line: Common Drug Review

Generic Name: Dutasteride

Brand Name: Avodart

Manufacturer: GlaxoSmithKline Inc.

Indications: Prostatic hyperplasia, benign

Submission Type: New

Project Status: Complete

Date Recommendation Issued: January 20, 2005

Recommendation Type: List in a similar manner to other drugs in class